• Rezultati Niso Bili Najdeni

Pdf_datoteka

N/A
N/A
Protected

Academic year: 2022

Share "Pdf_datoteka"

Copied!
8
0
0

Celotno besedilo

(1)

6ORY3HGLDWU

'$-$1-(%,2/2â.,+,1267$/,+3$5(17(5$/1,+='5$9,/

35,.521,ý1,+%2/1,.,+='5$9679(129=*2-12'(/2

=$9$512'$-$1-(9'20$ý(02.2/-8

$33/,&$7,212)%,2/2*,&$/$1'27+(53$5(17(5$/

0(',&$7,216,1&+521,&3$7,(176+($/7+('8&$7,21 FOR SAFE APPLICATION AT HOME

,.XþLQLþ..RUHQLQ

6OXåED]DDOHUJRORJLMRUHYPDWRORJLMRLQNOLQLþQRLPXQRORJLMR8QLYHU]LWHWQLNOLQLþQLFHQWHU /MXEOMDQD3HGLDWULþQDNOLQLND/MXEOMDQD6ORYHQLMD

6OXåED]DSOMXþQHEROH]QL8QLYHU]LWHWQLNOLQLþQLFHQWHU/MXEOMDQD 3HGLDWULþQDNOLQLND/MXEOMDQD6ORYHQLMD

,=9/(ý(.

=UD]YRMHPQRYLK]GUDYLOVHMHNDNRYRVWREUDYQDYHNURQLþQLKEROQLNRYELVWYHQRL]EROMãDOD9HOLNR]GUDYLO VLGDQHVEROQLNLODKNRGDMHMRVDPLGRPDLQEROQLãQLFRRELVNXMHMROHRENRQWUROQLKSUHJOHGLK6SUHQRVRP ]GUDYOMHQMD L] EROQLãQLFH QD GRP VNUE ]D ]GUDYMH SUHY]HPDMR EROQLNL R] QMLKRYL VWDUãL =GUDYOMHQMH QD GRPX]DKWHYDXþLQNRYLWRLQNDNRYRVWQR]GUDYVWYHQRY]JRMQRGHORPHGLFLQVNHVHVWUHNLRWURNHLQVWDUãH SRXþLNDNRVKUDQMHYDWLSUDYLOQRSULSUDYLWLLQGDMDWLSUHGSLVDQR]GUDYLOR6VYRMLPGHORPPHGLFLQVNDVHVWUD SUHY]DPHYORJR]GUDYVWYHQHJDGHODYFDXþLWHOMDLQSVLKRORJD8UHVQLþHYDQMHWHRGJRYRUQHQDORJH]DKWHYD L]YUVWQHYHãþLQHNRPXQLFLUDQMDVNDWHULPLVHPHGLFLQVNDVHVWUDSULEOLåDWDNRRWURNRPNRWWXGLQMLKRYLP VWDUãHP

.OMXþQHEHVHGH]GUDYVWYHQDQHJD]GUDYVWYHQRY]JRMQRGHORPHGLFLQVNDVHVWUDNURQLþQLEROQLNEL- RORãND]GUDYLODDQWLELRWLNL

ABSTRACT

7KHGHYHORSPHQWRIQHZPHGLFDWLRQVKDVVLJQL¿FDQWO\LPSURYHGWKHWUHDWPHQWRIFKURQLFSDWLHQWV0DQ\

PHGLFDWLRQVFDQEHDGPLQLVWHUHGDWKRPH3DWLHQWVRQO\FRPHWRKRVSLWDOIRUFKHFNXSV:LWKWKHWUDQVIHURI WUHDWPHQWIURPKRVSLWDOWRKRPHWKHSDUHQWVDQGSDWLHQWVWDNHFDUHRIWKHFKLOG¶VKHDOWK+HDOWKHGXFDWLRQ ZKHUHWKHQXUVHH[SODLQVKRZWRVWRUHSUHSDUHDQGJLYHWKHSUHVFULEHGPHGLFLQHSOD\VDYHU\LPSRUWDQW UROH7KHQXUVHSOD\VDYHU\LPSRUWDQWUROHDVDKHDOWKSURIHVVLRQDOWHDFKHUDQGSV\FKRORJLVW&RPPXQLFD- WLRQVNLOOVDUHYHU\LPSRUWDQWLQHQDEOLQJWKHQXUVHWRJHWFORVHUWRWKHSDUHQWVDQGWKHLUFKLOG

.H\ZRUGVQXUVLQJFDUHKHDOWKHGXFDWLRQQXUVHFKURQLFSDWLHQWDQWLELRWLFV

(2)

892'

=GUDYOMHQMHNURQLþQLKEROQLNRYVHMHY]DGQMLKQH- NDM OHWLK ]HOR VSUHPHQLOR VDM GDQHV QL QHL]RJLEQR YH]DQRVDPRQDEROQLãQLFRDPSDNVHYHþLQDEROQL- NRY]GUDYLWXGLGRPD=GUDYOMHQMHQDGRPXELVWYH- QRL]EROMãDNDNRYRVWåLYOMHQMDEROQLNDLQQMHJRYLK VWDUãHY+NDNRYRVWQLREUDYQDYLRGORþLOQRSULVSHYD PHGLFLQVNDVHVWUDNLVVWURNRYQRXVSRVREOMHQRVWMR VWDUãHLQRWURNHSRXþLRSUDYLOQHPGDMDQMXSUHGSLVD- QLK]GUDYLOKNUDWLSDMLKVH]QDQLWXGLVSUHSR]QDYD- QMHPQHåHOHQLKXþLQNRY]GUDYLOLQXNUHSDQMHPþH VHSRMDYLMR

%,2/2â.$='5$9,/$

/HWDMHPLQLORåHOHWRGUHJLVWUDFLMHSUYLK bioloških zdravil rekombinantnega izvora ter ra- VWQHJDKRUPRQDLQLQ]XOLQD7UHQXWQRMHUHJLVWULUD- QLKYHþNRWUHNRPELQDQWQLK]GUDYLOQLKXþLQNR- YLQ SUYH JHQHUDFLMH LQ YHþ NRW UHNRPELQDQWQLK ]GUDYLOGUXJHJHQHUDFLMH%LRORãND]GUDYLODXSR- rabljamo za zdravljenje raka ter imunskih in vne- WQRSRJRMHQLKEROH]QL96ORYHQLMLMH]D]GUDYOMHQMH RGREUHQLKYHþNRWELRORãNLK]GUDYLO1DVYHWRYQL UDYQLVRYOHWXQDMYHþXSRUDEOMDOLHWDQHUFHSW LQÀLNVLPDELQULWXNVLPDE

%LRORãND ]GUDYLOD VR ]HOR XþLQNRYLWD LPDMR HGLQ- VWYHQR WDUþR Y PROHNXODUQL SDWRJHQH]L RKUDQMDMR LPXQRVWL]SUHWHNORVWLRPRJRþDMRXþLQNRYLWHLPXQ- ske odzive v obdobju uporabe in se hitro odstranijo L]WHOHVD%LRORãNDLQELRORãNLPSRGREQD]GUDYL- ODVHPHGVHERMVWUXNWXUQRUD]OLNXMHMR=DUDGLNRP- SOHNVQHVHVWDYH]DSOHWHQLKSRVWRSNRYSURL]YRGQMH analize ter shranjevanja in rokovanja moramo z nji- mi ravnati še bolj previdno in dosledno kot z zdra- YLOLNLYVHEXMHMRNHPLMVNRVLQWHWL]LUDQHXþLQNRYLQH

9VDELRORãND]GUDYLODVR]HORGUDJD]DWRUD]YLMDMR SRGREQDELRORãND]GUDYLODNLELELODSRGREQRXþLQ- NRYLWDDREQLåMLFHQL

*ODYQL QHåHOHQL XþLQHN ELRORãNLK ]GUDYLO MH SUHG- YVHPYHOLNRWYHJDQMHRNXåE]DWRPRUDPREROQLNH in njihove starše o tem obvezno seznaniti in jim predstaviti preventivne ukrepe za njihovo prepre- þHYDQMH &HSOMHQMH ] åLYLPL FHSLYL SULSRURþDPR L]NOMXþQR SUHG SULþHWNRP ]GUDYOMHQMD PHGWHP NR ostala cepljenja lahko opravimo tudi med zdravlje- QMHP 3UL YVHK EROQLNLK SUL NDWHULK MH SUHGYLGHQR ]GUDYOMHQMH]ELRORãNLPL]GUDYLOLPRUDPRREYH]QR L]NOMXþLWLPRUHELWQRWXEHUNXOR]RVWXEHUNXOLQVNLP WHVWRPDOLVWHVWRP33'2ERNXåEDK]GUDYOMHQMH ] ELRORãNLP ]GUDYLORP ]DþDVQR SUHNLQHPR SUHG prekinitvijo zdravljenja pa se moramo o tem vedno SRVYHWRYDWL]OHþHþLP]GUDYQLNRP

,QIRUPDFLMRXSRUDELELRORãNLK]GUDYLOPHGQRVHþ- QRVWMRMHPDOR9HOMDVSORãQRSULSRURþLORGD]GUD- YOMHQMH]ELRORãNLP]GUDYLORPPHGQRVHþQRVWMRSUH- NLQHPRYHQGDURWHPYHGQRUD]SUDYOMDPR]DYVDN SULPHUSRVHEHM

&,7267$7,.,

0HWRWUHNVDW MH XþLQNRYLWR ]GUDYLOR ]D ]GUDYOMHQMH MXYHQLOQHJDLGLRSDWVNHJDDUWULWLVDMXYHQLOQHJDGHU- PDWRPLR]LWLVDLQGUXJLKNRåQLKEROH]QLYYLVRNLK odmerkih pa ga uporabljamo tudi za zdravljenje UDND 0HWRWUHNVDW ]PDQMãXMH GHORYDQMH LPXQVNHJD VLVWHPD V þLPHU SUHSUHþXMH GD EL QDãH REUDPEQH FHOLFHQDSDGDOHODVWQHFHOLFH

Metotreksat je na voljo v obliki tablet in kot razto- SLQD]DLQMLFLUDQMH%ROQLN]GUDYLORMHPOMHOHHQNUDW WHGHQVNRYHGQRLVWLGDQYWHGQX1DþLQGDMDQMDLQ RGPHUHN GRORþL ]GUDYQLN QD RVQRYL EROQLNRYHJD NOLQLþQHJDVWDQMD7DEOHWHVHEROMHUHVRUELUDMRþHMLK EROQLN]DXåLMHQDWHãþHLQ]YRGR=GUDYLORYREOL- NLDPSXO]DLQMLFLUDQMHODKNRYEUL]JDPRSRGNRåR NRWLQ]XOLQVNHLQMHNFLMHSULVODGNRUQLKEROQLNLKDOL YPLãLFR]HORUHGNRYYHQR*ODYQHSUHGQRVWLPH- totreksata v obliki raztopine za injiciranje so boljša

(3)

UHVRUSFLMD YLãMD NRQFHQWUDFLMD ]GUDYLOD Y WHOHVX LQ PDQMSUHEDYQLKWHåDYåHORGHF=GUDYOMHQMH]PH- WRWUHNVDWRP MH GROJRWUDMQR VDM YHþLQD ]GUDYQLNRY SULSRURþDQDGDOMHYDQMH]GUDYOMHQMD]PHWRWUHNVDWRP ãHQDMPDQM±PHVHFHYSRXPLULWYLUHPLVLMLER- OH]QL

9HþLQDRWURNNLVH]GUDYL]PHWRWUHNVDWRPLPD]HOR PDORQHåHOHQLKXþLQNRY1DMSRJRVWHMãDVWDVODERVW LQWLãþDQMHYåHORGFXNLVHMLPDODKNRXVSHãQRL]- RJQHPR]]DXåLWMHP]GUDYLODSRQRþL=DSUHSUHþH- YDQMHQHåHOHQLKXþLQNRYQDYDGQRSUHGSLãHPRIROQR NLVOLQR 9þDVLK VR SRWUHEQH GRGDWQH WDEOHWH SURWL VODERVWL NL MLK EROQLN Y]DPH SUHG MHPDQMHP PH- WRWUHNVDWDLQSRQMHP2EWUGRYUDWQLVODERVWLODKNR VSUHPHQL QDþLQ GDMDQMD LQ SUHLGH QD YEUL]JDYDQMH 2VWDOLQHåHOHQLXþLQNLVRUD]MHGHYXVWLKLQUHGNHMH NRåQLL]SXãþDM.DãHOMLQWHåDYH]GLKDQMHPVRSUL RWURFLK UHGNH 9SOLY PHWRWUHNVDWD QD ]PDQMãDQMH ãWHYLODNUYQLKFHOLFMHRELþDMQR]HOREODJ3ULRWUR- FLKVHRE]GUDYOMHQMX]PHWRWUHNVDWRPYQDVSURWMX ] RGUDVOLPL EROQLNL ]HOR UHGNR SRMDYL GROJRWUDMQD RNYDUDMHWHU¿EUR]DMHWHUYHUMHWQR]DUDGLELVWYHQR manjše izpostavljenosti dodatnim škodljivim vpli- YRPQDMHWUDXåLYDQMHDONRKRODSULRWURFLK

=GUDYOMHQMH]PHWRWUHNVDWRP]DþDVQRSUHNLQHPRþH RENRQWUROQHPSUHJOHGXXJRWRYLPRSRYHþDQHYUH- GQRVWLMHWUQLKHQFLPRYSRQMLKRYLQRUPDOL]DFLMLSD]

]GUDYOMHQMHPQDGDOMXMHPR9HGQRPRUDPRSRVNUEH- WL]DUHGQHODERUDWRULMVNHSUHLVNDYH7YHJDQMHRNXåE pri zdravljenju z metotreksatom navadno ni pove- þDQR0ODGRVWQLNHNLVH]GUDYLMR]PHWRWUHNVDWRP RSR]RULPRGDMHPHG]GUDYOMHQMHP]DUDGLãNRGOML- YLK XþLQNRY QD MHWUD VWURJR SUHSRYHGDQR XåLYDQMH DONRKROQLKSLMDþ6SROQRDNWLYQHPODGRVWQLNHSRX- þLPRRQXMQRVWLXSRUDEHNRQWUDFHSFLMVNLKVUHGVWHY VDMPHWRWUHNVDWODKNRSRY]URþLRNYDURSORGD

,0812*/2%8/,1,

,PXQRJOREXOLQMHVLQRQLP]DSURWLWHOR,QWUDYHQVNL LPXQRJOREXOLQL ,9,* VR SULSUDYOMHQL L] YHOLNH

NROLþLQHNUYQHSOD]PH]GUDYLKNUYRGDMDOFHY,9,*

pri otrocih uporabljamo za zdravljenje bolezen- skih stanj s pomanjkanjem protiteles zaradi okvare LPXQVNHJDVLVWHPD0HKDQL]PLGHORYDQMD,9,*ãH vedno niso povsem pojasnjeni in se verjetno razli- NXMHMR JOHGH QD EROH]HQVNR VWDQMH 8þLQNRYLWR MLK uporabljamo pri nekaterih avtoimunskih in revmat- VNLKEROH]QLK'DMHPRMLKYLQWUDYHQVNLLQIX]LMLSR UD]OLþQLKVKHPDKRGYLVQRRGEROH]QL

1HåHOHQLXþLQNLVRUHGNLLQREVHJDMRDQD¿ODNWLþQH DOHUJLMVNHUHDNFLMHEROHþLQHYPLãLFDKYURþLQRLQ glavobol med infuzijo ter glavobol in bruhanje za- UDGLQHLQIHNWLYQHJDGUDåHQMDPRåJDQVNLKRYRMQLFW LDVHSWLþQLPHQLQJLWLVXUSRLQIX]LML7LQHåHOHQL XþLQNL VSRQWDQR L]]YHQLMR 3UL QHNDWHULK EROQLNLK SUHGYVHP V .DZDVDNLMHYR EROH]QLMR LQ SRPDQMND- QMHP DOEXPLQRY ODKNR RE SUHMHPDQMX ,9,* SULGH GR ]QLåDQMD NUYQHJD WODND ]DWR MLK PRUDPR PHG ]GUDYOMHQMHPVNUEQRVSUHPOMDWL,9,*QHYVHEXMHMR YLUXVD+,9YLUXVRYKHSDWLWLVDLQGUXJLK]QDQLKYL- UXVRY

='5$9/-(1-( = $17,%,27,., 35,

%2/1,.,+6&,67,ý12),%52=2

&LVWLþQD ¿EUR]D &) MH QDMSRJRVWHMãD DYWRVRPQR UHFHVLYQD EROH]HQ WRUHM JHQHWVND EROH]HQ NL MR RWURN SRGHGXMH þH SUHMHPH RNYDUMHQ JHQ RG REHK VWDUãHY3RGDWNLL]UHJLVWURYEROQLNRYNDåHMRGDVH MHSULþDNRYDQDåLYOMHQMVNDGREDOMXGLV&)Y]DGQMLK nekaj desetletjih zaradi napredka v zdravljenju z an- tibiotiki in nadomestki encimov trebušne slinavke ter zaradi podpornega prehranskega zdravljenja in FHORYLWHREUDYQDYHYFHQWULK]D&)PRþQRSRGDOM- ãDOD

1DMYHþMDQHYDUQRVW]DEROQLNHV&)MHRNXåED]EDN- terijo 3VHXGRPRQDVDHUXJLQRVD3UYRRNXåER]QMR ]GUDYLPRHUDGLNDFLMVNRWMWDNRMXYHGHPRDJUHVLY- QRYHþWLUQRDQWLELRWLþQR]GUDYOMHQMHQDMSUHMVSHUR- UDOQLPLLQLQKDODWRUQLPLDQWLELRWLNLREQHXVSHãQRVWL ãH]LQWUDYHQVNLPLDQWLELRWLNL

(4)

9 VYHWX åH YHþ OHW L]YDMDMR LQWUDYHQVNR ]GUDYOMH- QMH]DQWLELRWLNLQDGRPX7RSRPHQLGDVRYHOLN del odgovornosti prevzeli tako zdravstveni delavci NRWWXGLVDPLEROQLNLR]QMLKRYLVYRMFL3UYLRSLVL LQWUDYHQVNHJD ]GUDYOMHQMD L]YLUDMR åH L] OHWD

=GUDYOMHQMHQDGRPXEROQLNRPLQQMLKRYLPVYRMFHP RPRJRþDYHþMRNDNRYRVWåLYOMHQMDLQãWHYLOQHSUHG- QRVWL VDM MH YVDNRGQHYQR RELVNRYDQMH EROQLãQLFH YHOLND¿QDQþQDLQþDVRYQDREUHPHQLWHY=LQWUDYHQ- skim zdravljenjem na domu se prav tako pomemb- QR]PDQMãDMRVWURãNL]GUDYOMHQMDYEROQLãQLFLNDUSD QHVPHSRVWDWLRVQRYQLFLOM

,]VOHGNLãWHYLOQLKUD]LVNDYNDåHMRGDMHLQWUDYHQVNR ]GUDYOMHQMHYEROQLãQLFLEROMXþLQNRYLWRNHUL]EROM- ãDQMHSOMXþQHIXQNFLMHQDVWRSLKLWUHMH3RJRVWL]DSOH- WL]GUDYOMHQMDYGRPDþHPRNROMXVRSUHGYVHPWHK- QLþQHQDUDYHQSUWURPER]DRNOX]LMDLQWUDYHQVNHJD NDQDODSUHSXãþDQMHLQWUDYHQVNHJDNDQDOD2NXåEH SRYH]DQH ] QDVWDYLWYLMR LQWUDYHQVNHJD NDQDOD VR UHGNH*OHGHQDUD]SRORåOMLYHSRGDWNHMHSRMDYQRVW WHKQLþQLK WHåDY QD SULPHURY SRMDYQRVW RNXåE]DUDGLLQWUDYHQVNLKNDQDORYSDQD SULPHURY

9 &HQWUX ]D &) QD 3HGLDWULþQL NOLQLNL Y /MXEOMDQL VPRVH]DWRRGORþLOLGDLQWUDYHQVNR]GUDYOMHQMHQD GRPXXYHGHPRSULWLVWLKEROQLNLKNLJOHGHQDNOL- QLþQR VWDQMH L]SROQMXMHMR PHULOD ]D ]GUDYOMHQMH QD GRPXLQVLWHJDåHOLMRSROHJWHJDSDPRUDMRELWL]D izvajanje zdravljenja na domu pripravljeni tudi nji- KRYLVWDUãL9OHWLKLQVPR]D]GUDYOMH- QMHQDGRPXXVSHãQRXVSRVRELOLSHWGUXåLQRWURNLQ PODGRVWQLNRYVFLVWLþQR¿EUR]R

3ULRGORþDQMXRYNOMXþLWYLEROQLNDV&)YSURJUDP zdravljenja z intravenskimi antibiotiki na domu upoštevamo naslednja merila:

‡ $OLMHEROQLNYGRYROMGREUHPVWDQMX]DRGSXVW iz bolnišnice?

‡ $OL LPD EROQLN Y GRPDþHP RNROMX XVWUH]QR SRGSRUR NL ER ]DJRWRYLOD XVWUH]QR GDMDQMH LQWUDYHQVNLK ]GUDYLO WM SUDYRþDVQR SUDYLOQR in v celoti?

‡ $OLLPDEROQLNSRGSRURYGRPDþHPRNROMXY VPLVOX]DJRWDYOMDQMDUHGQH¿]LRWHUDSLMHSUDYLO- QHJDSUHKUDQMHYDQMD]DGRVWQHJDYQRVDWHNRþLQ LQGRYROMSRþLWND"

‡ $OLEROQLNLQDOLGUXåLQDODKNR]DJRWDYOMDGR- EURVNUE]DLQWUDYHQVNLNDQDODOLFHQWUDOQLåLOQL NDWHWHU SUHSR]QDYD QHåHOHQH XþLQNH ]GUDYLOD LQYHNDNRXNUHSDWLþHVHSRMDYLMR"

‡ $OL EROQLN LQDOL GUXåLQD VLFHU GREUR VRGHOXMH v procesu zdravljenja in upošteva ostalo pred- pisano zdravljenje?

‡ $OLEROQLNGUXåLQDGREURUD]XPHRGJRYRUQRVWL in tveganja ob izvajanju intravenskega zdra- YOMHQMDQDGRPX"

3UYHL]NXãQMHVRSRND]DOHGDVREROQLNLLQQMLKRYL VWDUãLVWDNãQLPQDþLQRP]GUDYOMHQMD]HOR]DGRYROM- QL YHQGDU MH ]DQMH WXGL GRGDWQR EUHPH =HOR SR- PHPEQRMHGDJODYQLUD]ORJ]GUDYOMHQMDQDGRPX ni pomanjkanje bolniških postelj ali zmanjšanje EROQLãQLþQLKVWURãNRYDPSDNUHVQLþQDåHOMDEROQLND LQ GUXåLQH SR VDPRVWRMQHP ]GUDYOMHQMX RE KNUDWQL RFHQL]GUDYVWYHQLKGHODYFHYGDVRWDNãQHJDQDþLQD ]GUDYOMHQMD]PRåQLLQVSRVREQL

35,35$9$ %2/1,.$ 1$ '$-$1-(

='5$9,/$9'20$ý(02.2/-8

‡ %ROQLNX R] VWDUãHP SUHGVWDYLPR QDþUW ]GUD- YOMHQMD

‡ 2FHQLPRQMLKRYR]PRåQRVW]DL]YDMDQMHLQWUD- YHQVNHJDDQWLELRWLþQHJD]GUDYOMHQMDQDGRPX

‡ 3ULSUDYLPR SULSRPRþNH R] PDWHULDO ]D LQWUD- YHQVNRGDMDQMHDQWLELRWLNRY

‡ 3UDNWLþQR SULNDåHPR SULSUDYR LQ GDMDQMH DQ- WLELRWLND

‡ 6WDUãL R] EROQLN VNXSDM ] PHGLFLQVNR VHVWUR pripravijo intravenski antibiotik in ga vbri- ]JDMR

‡ 2FHQLPR]PRåQRVWL]DL]YDMDQMHLQWUDYHQVNHJD DQWLELRWLþQHJD]GUDYOMHQMDQDGRPX

‡ 8þQL SURJUDP L]GHODPR Y REOLNL WDEHOH KLJL- HQD ELYDOQHJD RNROMD SULSUDYD SULSRPRþNRY

(5)

]D SUHEUL]JDYDQMH SULSUDYD SULSRPRþNRY ]D GDMDQMHDQWLELRWLNDSULSUDYD]GUDYLOD±EROXV SULSUDYD]GUDYLOD±LQIX]LMDQHåHOHQLXþLQNL±

RSD]RYDQMH SUHSR]QDYDQMH LQ XNUHSDQMH GR- VHåHQD VWRSQMD ]QDQMD ± EROQLN MH WHRUHWLþQR VH]QDQMHQ]YVHELQREROQLNMHSUDNWLþQRVH]QD- QMHQ]YVHELQREROQLNSRVWRSHNL]YHGHVDP

‡ Ponovno se pogovorimo o dajanju antibiotikov LQQHåHOHQLKXþLQNLK]GUDYLOD

‡ 7HPHOMLWR VH SRJRYRULPR R Y]GUåHYDQMX LQ- WUDYHQVNH NDQLOH LQ XNUHSDQMX þH PRUGD QH GHOXMHSUDYLOQR

‡ 3UDNWLþQR SUHGVWDYLPR XSRUDER (SL3HQD® v SULPHUXDQD¿ODNWLþQHUHDNFLMH

‡ %ROQLNX R] VWDUãHP L]URþLPR SLVQD QDYRGLOD RSULSUDYLLQWUDYHQVNHJDDQWLELRWLND

‡ 3UHYHULPRUD]XPHYDQMHQDYRGLO

‡ =QDQMH UHGQR SUHYHUMDPR RE NRQWUROQLK SUH- JOHGLK

8þHQMHSULSUDYHLQGDMDQMDDQWLELRWLNDSUHNRLQWUD- YHQVNHJD NDQDOD SRWHND LQGLYLGXDOQR LQ SRVWRSQR WMSRNRUDNLK7RYSUDNVLSRPHQLGDEROQLNQH- NDM þDVD SUHMHPD DQWLELRWLþQR ]GUDYOMHQMH Y EROQL- ãQLFLSRGQDG]RURPýHQLPDWHåDYSULSUHMHPDQMX DQWLELRWLNDODKNRSULþQH]XþHQMHP]DVDPRVWRMQR GDMDQMH

%ROQLNSUHMPHWXGLQDWDQþQDQDYRGLODNDNRXNUHSD- ti ob morebitnem pojavu naslednjih znakov:

‡ L]SXãþDM

‡ VODERVW

‡ SRYLãDQDWHOHVQDWHPSHUDWXUD

‡ EUXKDQMH

‡ QDQDYDGQLREþXWNL

‡ WHåNRGLKDQMH

‡ RWHNOLQDRNURJYUDWX

Ob pojavu katerega koli od naštetih znakov dajanje zdravila takoj prekinemo in stopimo v stik z zdrav- QLNRPR]SRNOLþHPRQXMQRPHGLFLQVNRSRPRþQD WHOHIRQVNRãWHYLONR

7UDMDQMHDQWLELRWLþQHJD]GUDYOMHQMDYHGQRSUHGSLãH ]GUDYQLN PHGWHP NR PHGLFLQVND VHVWUD SULSUDYL PDWHULDOLQ]GUDYLOD

='5$9/-(1-(9%2/1,â1,&,

Prednosti:

‡ QDG]RUQDGSUHMHPDQMHP]GUDYOMHQMD

‡ VSUHPOMDQMH]GUDYVWYHQHJDVWDQMD

‡ GDMDQMH]GUDYLOQDGDOMãHREGREMH

‡ QDG]RURYDQDSULSUDYD]GUDYLOD Slabosti:

‡ SRJRVWHRGVRWQRVWLL]ãROHLQVOXåEH

‡ QXMQRVWNRULãþHQMDGRSXVWDVWDUãL

‡ HNRQRPVNLUD]ORJLL]RVWDQNLL]VOXåEHVWURãNL SUHYR]D

‡ L]SRVWDYOMHQRVWEROQLãQLþQLPRNXåEDP

='5$9/-(1-(1$'208

Prednosti:

‡ enakomerna koncentracija imunoglobulinov v NUYL

‡ UHGQRRELVNRYDQMHãROHLQVOXåEHEUH]L]RVWD- MDQMD

‡ QLåMLVWURãNL

‡ PDQMãDL]SRVWDYOMHQRVWEROQLãQLþQLPRNXåEDP Slabosti:

‡ QHQDG]RURYDQRGDMDQMH]GUDYLOD

‡ SRJRVWRVW GDMDQMD ]GUDYLOD HQNUDW QD WHGHQ GYDNUDWQDWHGHQDOLFHORYVDNGDQUD]HQSUL VXENXWDQHPGDMDQMX

‡ YSUDãOMLYRVWDVHSWLþQHSULSUDYH]GUDYLOD

‡ vprašljivost ustreznega shranjevanja zdravila LQ]DJRWDYOMDQMDKODGQHYHULJH

(6)

='5$9679(129=*2-12'(/2 0(',&,16.(6(675(

.RPXQLNDFLMD

.HU EROH]HQ LQ ]GUDYLOD YVDNGR GRMHPD GUXJDþH VSORãQHJDSUDYLODNRPXQLFLUDQMDQHSR]QDPRLQGL- YLGXDOQDREUDYQDYD9HGQRVHSRVWDYLPRYYORJR EROQLNDVDMMHGREUDNRPXQLNDFLMDRURGMHVNDWHULP VSRGEXGLPR]DQLPDQMH]D]GUDYOMHQMHNLMHYSRY- SUHþMXSULVRWQRSULVDPRSRORYLFLEROQLNRY1H]DGR- stno zanimanje za zdravljenje je ena glavnih ovir pri ]DJRWDYOMDQMX XþLQNRYLWH ]GUDYVWYHQH RVNUEH %RO- QLNQDM]DþXWLGDVPRYERMXSURWLQMHJRYLEROH]QL ]DYH]QLNL]DWRPHGVHERMQR]DXSDQMHJUDGLPRåHRG YVHJD]DþHWND8SRãWHYDWLPRUDPREROQLNRYDVWDOL- ãþDSRPHPEQRSDMHWXGLVRGHORYDQMH=XþLQNRYLWR NRPXQLNDFLMR SUHVHåHPR GXãHYQH RYLUH SRYH]DQH ] MHPDQMHP ]GUDYLO SR]DEOMLYRVW QH]DXSDQMH GR ]GUDYQLND LQ IDUPDFHYWD VODER ]DYHGDQMH UHVQRVWL EROH]QL SHVLPL]HP JOHGH ]GUDYMD Y SULKRGQRVWL SUHSUHNH]DUDGLMH]LNDR]UD]XPHYDQMDVODEDPRWL- YLUDQRVWVWUDKSUHGQHåHOHQLPLXþLQNL]GUDYLOD]D- QLNDQMHEROH]QLGUXJDþQRGRMHPDQMHEROH]QLVWUDK SUHGWYHJDQMLQHåHOHQLKXþLQNRY]DSOHWHQSRVWRSHN MHPDQMD ]GUDYLO 3RVOHGLFH SRPDQMNOMLYH NRPXQL- NDFLMHVRQHMHPDQMHDOLQHGRVOHGQRMHPDQMH]GUDYLO QHXþLQNRYLWR ]GUDYOMHQMH SRJRVWHMãL ]DSOHWL EROH- ]QLãWHYLOQHGRGDWQHKRVSLWDOL]DFLMHLQYLãMLVWURãNL

=DWRVLPRUDPRYHGQRY]HWLGRYROMþDV]DWHPHOMLW SRJRYRU

,]REUDåHYDQMHEROQLNRY

‡ 9SUYLID]LPHGLFLQVNDVHVWUDFHORWHQSRVWRSHN L]YHGHVDPRVWRMQR

‡ 9GUXJLID]LSRVWRSHNL]YHGHMRRWURFLLQVWDUãL DRESRPRþLLQQDG]RUXPHGLFLQVNHVHVWUH

‡ 9 WUHWML ID]L VWDUãL LQ RWURFL L]YHGHMR FHORWHQ SRVWRSHNVDPLEUH]SRPRþLPHGLFLQVNHVHVWUH

%LRORãND]GUDYLOD

=D VWDUãH LQ RWURNH RUJDQL]LUDPR XþQH GHODYQLFH 9HGQR SRWHNDMR LQGLYLGXDOQR EROQLNL LQ VWDUãL SD VH MLK XGHOHåXMHMR GRNOHU QH REYODGDMR SRVWRSND YDUQHJDGDMDQMD]GUDYLODYGRPDþHPRNROMX8þQH GHODYQLFHSRWHNDMRYWUHKID]DK

3UYD ID]D =D VWDUãH LQ RWURNH RUJDQL]LUDPR XþQH GHODYQLFHNLMLKRELãþHMRYVDMWULNUDW9VDNHJDERO- QLNDREUDYQDYDPRSRVHEHM2ESUYHPRELVNXSUHG- stavimo zdravilo ter postopek priprave in dajanja ]GUDYLODNLSDJDYFHORWLL]YHGHPHGLFLQVNDVHVWUD 9 WHRUHWLþQHP GHOX RSLãH ]GUDYLOR QDþLQ VKUDQMH- YDQMD LQ WUDQVSRUW KODGQD YHULJD QDþLQ SULSUDYH SURVWRUDLQGHORYQHSRYUãLQHSULSUDYRRVHEHLQSR- VHEQRVWL]GUDYLODURNXSRUDEHXSRUDEQRVW]GUDYL- OD SR SULSUDYL VHJUHYDQMH ]GUDYLOD SUHG XSRUDER 1DWDQþQR SUHGVWDYL SRVWRSHN SULSUDYH ]GUDYLOD LQ RGPHUMDQMH]GUDYLODSULSUDYREROQLNDLQL]ELURYER- GQHJD PHVWD 6SUHJRYRUL R XVWUH]QHP UDYQDQMX ] RGSDGNL,]URþLMLPSLVQHLQIRUPDFLMHLQQDYRGLOD]D SULGRELYDQMHUHFHSWD

9GUXJLID]LXþHQMDVHYL]YHGERSRVWRSNDDNWLYQR YNOMXþLMRRWURNLQQMHJRYLVWDUãL0HGLFLQVNDVHVWUD staršem in otroku pomaga pri pripravi in dajanju ]GUDYLOD )D]R SRQDYOMDPR GRNOHU VWDUãL LQ RWURFL SULL]YHGELQLVRSRYVHPVDPRVWRMQL

7UHWMHID]HXþQHGHODYQLFHVHVWDUãLLQRWURFLXGH- OHåLMR NR SRVWRSHN Y FHORWL L]YHGHMR SRYVHP VD- PRVWRMQRLQVRþXWLMRXVSRVREOMHQL]DYDUQRGDMDQMH ]GUDYLOD GRPD 2E WUHWMHP RELVNX VWDUãL DOL RWURFL samostojno izvedejo postopek priprave in dajanja ]GUDYLOD SRG QDG]RURP PHGLFLQVNH VHVWUH 3R SR- WUHELODKNRVWDUãLRELãþHMRGRGDWQHXþQHGHODYQLFH GRNOHUGDMDQMD]GUDYLODQHREYODGDMR

(7)

&LWRVWDWLNL

7XGL]DVWDUãHLQRWURNHVSUHGSLVDQLPFLWRVWDWLþQLP ]GUDYOMHQMHP Y REOLNL LQMHNFLM RUJDQL]LUDPR XþQH GHODYQLFH2SLãHPR]GUDYLORMLKSRXþLPRRSUDYLO- QHPVKUDQMHYDQMXWHUSULSUDYLSURVWRUDLQGHORYQH SRYUãLQH1D]RUQRMLPSRNDåHPRPHVWRGHMDQMDLQ VDPR L]YHGER SRVWRSND 3RXGDULPR WXGL QXMQRVW SUDYLOQHJDUDYQDQMD]QHYDUQLPLRGSDGNL

6XENXWDQLLPXQRJOREXOLQL

8þQHGHODYQLFHRUJDQL]LUDPRYVDMWULNUDW2EOHWQLK NRQWUROQLKSUHJOHGLKVSUHPOMDPRWXGLQDþLQSULSUD- ve in dajanje subkutanih imunoglobulinov preko þUSDONH1DXþQLKGHODYQLFDKSRXGDUMDPRXVWUH]HQ QDþLQVKUDQMHYDQMDLQWUDQVSRUWD]DUDGLQXMQRVWL]D- JRWDYOMDQMD KODGQH YHULJH 1DXþLPR MLK NDNR SUL- SUDYLMR PDWHULDO LQ SULSRPRþNH WHU VSUHJRYRULPR RSRVHEQRVWLK]GUDYLOD1DMSUHMSULSUDYLPRSURVWRU LQGHORYQRSRYUãLQR1DWRSULSUDYLPRãH]GUDYLOR JD RGPHULPR QDPHVWLPR VLVWHP ]D GDMDQMH LQ L]- EHUHPR YERGQR PHVWR 1DXþLPR MLK SRVWRSND GD- MDQMD QDPHVWLWHY VLVWHPD SUHYHUMDQMH YERGQHJD PHVWDURNRYDQMHVþUSDONRRGVWUDQMHYDQMHVLVWHPD ]DGDMDQMH]GUDYLOD6SUHJRYRULPRWXGLRUDYQDQMX ]RGSDGNL3RXþLPRMLKRXNUHSDQMXREPRUHELWQHP SRMDYXQHåHOHQLKXþLQNRY]GUDYLODWHUMLPGDPRWXGL pisna navodila z napotki za pridobitev recepta in po- WUHEQHJDPDWHULDOD

=$./-8ý(.

Pri zdravljenju otrok z revmatsko ali imunsko bole- ]QLMRNLJDL]YDMDMRVWDUãLVDPLYGRPDþHPRNROMX MHNOMXþQHJDSRPHQDGDREYODGDMRSRVWRSHNGDMD- QMD ]GUDYLOD 3RPHPEQR MH WXGL GD RWURND QD GD- MDQMHGXãHYQRSULSUDYLMR2WURNQDPUHþRGVWDUãHY SULþDNXMHGDJDERGREROHþLQHREYDURYDOLQLNDNRU SDSRY]URþDOL0HGLFLQVNDVHVWUDVHPRUDVWDUãHPLQ RWURNX ] XVWUH]QLP QDþLQRP NRPXQLNDFLMH QD SUL- PHUHQQDþLQSULEOLåDWLLQMLPELWLQDYROMR/HWDNR bomo zagotovili uspešno zdravljenje in kakovostno åLYOMHQMHFHORWQHGUXåLQH

/,7(5$785$

âWUXNHOM%5D]OLþQRVWELRORãNLK]GUDYLOLQSR- VHEQRVWLSULQMLKRYLREUDYQDYL9LGLNLXSRUDEH ELRORãNLK ]GUDYLO ± OHNDUQD 8.& /MXEOMDQD /MXEOMDQD 8QLYHU]LWHWQL NOLQLþQL FHQWHU /MX- EOMDQD

7RPDåLþ-%LRORãND]GUDYLODLQRNXåEH9LGLNL XSRUDEHELRORãNLK]GUDYLO±OHNDUQD8.&/MX- EOMDQD/MXEOMDQD8QLYHU]LWHWQLNOLQLþQLFHQWHU /MXEOMDQD

,KDQ $ ,PXQRORãNL YLGLNL SUL XSRUDEL ELR- ORãNLK ]GUDYLOLK 9LGLNL XSRUDEH ELRORãNLK ]GUDYLO ± OHNDUQD 8.& /MXEOMDQD /MXEOMDQD 8QLYHU]LWHWQLNOLQLþQLFHQWHU/MXEOMDQD 'RVHJOMLYR QD KWWSZZZ35,1- 72,7SHGLDWULFUKHXPDWRORJ\6,LQIR

=GUDYOMHQMH

'RVHJOMLYRQD

KWWSZZZUFKRUJDXXSORDGHG)LOHV0DLQ

&RQWHQWUKHXPDWRORJ\0HWKRWUH[DWHBSDUHQWB LQIRUPDWLRQSGI

$QWROLþ5.RPXQLNDFLMD]]GUDYQLNLEROQLNL LQVYRMFL9LGLNLXSRUDEHELRORãNLK]GUDYLO±OH- NDUQD8.&/MXEOMDQD/MXEOMDQD8QLYHU]LWHWQL NOLQLþQLFHQWHU/MXEOMDQD

3UDSURWQLN0.RWQLN3LUã$6DORELU%2ãWLU 0 7XUHO 0 .ULYHF 8 1RYRVWL Y REUDYQDYL SOMXþQH EROH]QL SUL RWURFLK LQ PODGRVWQLNLK V FLVWLþQR¿EUR]R=GUDY9HVWQ 0RRUH'/DQG%RUWROXVVL5&DQDGLDQ3DHGL- DWULF6RFLHW\,QIHFWLRXV'LVHDVHVDQG,PPXQL- ]DWLRQ&RPPLWWHH+RPHLQWUDYHQRXVWKHUDS\

$FFHVVLELOLW\IRU&DQDGLDQFKLOGUHQDQG\RXWK 3DHGLDWU&KLOG+HDOWK)HE 2ãWLU0.RUHQLQ.,QWUDYHQR]QDWHUDSLMDQD

GRPXSULSDFLHQWLKVFLVWLþQR¿EUR]R=ERUQLN SUHGDYDQM]UHFHQ]LMR

&\VWLF)LEURVLV+RPH7KHUDS\IRU,9$QWL- ELRWLFVGRVHJOMLYRQD

KWWSZZZQDWLRQZLGHFKLOGUHQVRUJF\VWLF¿- brosis-home-therapy

(8)

.RQWDNWQDRVHED&RQWDFWSHUVRQ ,QJULG.XþLQLþGLSOPV

6OXåED ]D DOHUJRORJLMR UHYPDWRORJRMR LQ NOLQLþQR imunologijo

8QLYHU]LWHWQLNOLQLþQLFHQWHU/MXEOMDQD 3HGLDWULþQDNOLQLND

%RKRULþHYDXOLFD 6,/MXEOMDQD Slovenija

(SRãWDLQJULGNXFLQLF#NFOMVL 3ULVSHOR5HFHLYHG 6SUHMHWR$FFHSWHG

Reference

POVEZANI DOKUMENTI

0RåQRVW XSRUDEH ,5 WHUPRJUDILMH ]D ]D]QDYDQMH QHNDWHULK WLSLþQLK QHSUDYLOQRVWL YRWOLNDYRVWL ]DGUåDQH YRGH RGVWRSDQMD SODVWL UD]SRN LQ YNOMXþNRY DUPDWXUH LQ instalacijskih cevi) v

Pivovarna Union je namreč v letu 2014 praznovala častitljivih 150 let, leto pa je minevalo tudi v pripravah na obeleževanje veličastne 190 letnice Pivovarne Laško v 2015..

zlomi, izpahi zaradi nezgode: če zavarovanec zaradi nezgode utrpi zlom ali izpah nekaterih sklepov, zavarovalnica krije nadomestilo v višini dogovorjene zavarovalne vsote ali

5RELGD$ 1DSDNH SUL ]GUDYVWYHQL REUDYQDYL SDFLHQWRY VLVWHPDWLþQD DQDOL]D JOREOMLK Y]UR- NRY QDSDN LQ QMLKRYR SUHSUHþHYDQMH %OHG Center za izboljševanje kakovosti in varnosti

1D .OLQLþQHP RGGHONX ]D RWURãNR NLUXUJLMR LQ LQ- WHQ]LYQRWHUDSLMRåHYUVWROHWSRWHNDL]REUDåHYDQMH VWDUãHYRRVNUELNURQLþQREROQHJDRWURNDQDGRPX

Prikazali smo deleže finančnih sredstev, ki jih za trženje nameni podjetje Alples in deleže, ki jih za to namenijo druga podjetja na slovenskem trgu!. Podali smo tudi

3RYH]DQRVW RUJDQL]DFLMVNH NXOWXUH LQ QRWUDQMHJD SRGMHWQLãWYD MH SRMDVQMHQD WXGL ] GHWHUPLQDFLMVNLPNRHILFLHQWRPVNDWHULPSRMDVQMXMHPRYDULDQFRRUJDQL]DFLMVNHNXOWXUHNMHU ODKNR V

Sokrat sprašuje Tujca iz Elee, kateri postopek namerava uporabiti za razpravljanje: d olge govore ali vprašanja in odgovore.. Tako, d en im o, lahko razpravljamo s